SCHEMBL10909327

SCHEMBL10909327

CCCC(C)(N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3533776 0.97 FDPS (0.39)
SCHEMBL2545678 0.83
SCHEMBL11097547 0.82
SCHEMBL11576404 0.80 FDPS (0.46)
Ammonia Solution, Strong SCHEMBL29055682 0.80 FDPS (0.38)
Hydrochloric Acid SCHEMBL28030030 0.80 FDPS (0.38)
SCHEMBL726014 0.79
SCHEMBL11102665 0.78 SMPD1 (0.48)
SCHEMBL28844286 0.78 CYP2D6 (0.43)
SCHEMBL11234308 0.78 SMPD1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119317482-A Delivery particles based on amine-thiol-ene conjugates and derivatives 恩盖普有限公司 2025-01-14 CN disclosed
EP-4010386-B1 METHOD OF IMPROVING SHEAR STABILITY OF HIGHLY CONCENTRATED AQUEOUS ADHESIVE POLYMER COMPOSITIONS BASF SE (DE) 2023-09-06 EP disclosed
CN-107406422-B Pyrazole derivatives as sGC stimulators 赛科理音医疗有限公司 2022-02-01 CN disclosed
EP-3194382-B1 PYRAZOLE DERIVATIVES AS SGC STIMULATORS CYCLERION THERAPEUTICS INC (US) 2021-09-08 EP disclosed
US-20210221793-A1 PYRAZOLE DERIVATIVES AS SGC STIMULATORS CYCLERION THERAPEUTICS, INC. 2021-07-22 US disclosed
US-20210094966-A1 PROCESS FOR PRODUCING A FIVE-MEMBERED POLYCYCLOALIPHATIC CARBONATE TEREOS STARCH & SWEETENERS BELGIUM (BE) 2021-04-01 US disclosed
WO-2021023568-A1 METHOD OF IMPROVING SHEAR STABILITY OF HIGHLY CONCENTRATED AQUEOUS ADHESIVE POLYMER COMPOSITIONS BASF SE (DE) 2021-02-11 WO disclosed
US-10662185-B2 Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-05-26 US disclosed
US-10662185-B2 Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-05-26 US disclosed
US-20190284168-A1 PYRAZOLE DERIVATIES AS SGC STIMULATORS IRONWOOD PHARMACEUTICALS, INC 2019-09-19 US disclosed
US-20150274719-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-10-01 US disclosed
US-20150274719-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-10-01 US disclosed
EP-2914594-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2015-09-09 EP disclosed
US-9126998-B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use Bayer Pharma AG (DE) 2015-09-08 US disclosed
US-20140179672-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-06-26 US disclosed
US-20140128372-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 US disclosed
WO-2014068099-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 WO disclosed
CN-103201315-A Copolyamide ARKEMA FRANCE 2013-07-10 CN disclosed
CN-85101113-A The preparation of novel platinum complexes 1987-01-17 CN disclosed
US-4607114-A ANTITUMOR AGENTS, LOWER RENAL TOXICITY NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1986-08-19 US disclosed